Friday, December 15, 2017

Plz DONATE

KAMDHENU(Regd.Trust)
Registered in section 12(A) No.CIT-1/T/120(K-41)Agra/2004-05/3261
Donations for this trust are eligible for tax relief U/S-80G of income tax act 1961

KAMDHENUDHAM, PATNAGARH
Our organization (kamdhenu) is a national organization.  we try to develop the poor-villages in Odisha by training the farmers on cow based cultivation and cottage industry with preserving forest, water, soil and wild life. In Odisha more than 200 villages have already been undertaken and village committees have been formed. For this purpose 7 acres of land has been taken (2.5 acres from donation) 13 Kilometers away from Patnagarh city.

What we humbly need from you:-
1- Cow shed: 60’x20’ tin thatched shed. Costing about =Rs. 3,60,000/-
2- Office: 20’x15’ R C C roof Costing about= Rs.150,000/-
3- Medicine manufacturing shed: 10’x40’ hall Costing about =Rs. 2,00,000/-
4- Compost(manure) making pit(10.no.s) 6’x12’x6’ pit@=Rs 5000/- each =Rs.50,000/-
5- Shelter for old age & disable Cattle (100 nos.) 40 sq. ft/cow , total 4000 sq ft @Rs. 30/ sq. ft = Rs. 1,20,000/-
6- Feed go-down (dried fodder store)= Rs. 50,000/-
7- Free health centre: 15’x20’ costing about Rs:1,80,000/-
8- Residential quarter: 4-no.s x 1,00,000/- =Rs. 4,00,000/-
9- Borewell ,motor and over head tank with all fittings Rs. 1,20,000/-

Objectives of KAMDHENUDHAM, PATNAGARH
1- Farmer training about cow based cultivation.
2- Ayurvedic (panchgavya) medicine.
3- Bio-organic product.
4- Self employment scheme for rural people.
5- Free health service.
6- Cottage industry.
7- Preservation and improvement of live stock.
8- Herbal garden.

For details plz visit: www.sevika.org/, www.kamdhenudham.blogspot.com/
Email:info@sevika.org, kamdhenudham@gmail.com/ymail.com
Mobile: +91 9938712663


Donation for Old Age Home


Donation for Old Age Home
AmountDetails
INRUSD
100020Medicines Boxes 
2000401 Meal / Bed Side Lockers / Bed Sheets
300060Almirah / Cup Board
5000100SEMI (Fowler) / Tilt Bed / A Days food
10,000200Television / Air Cooler
15,000300  Water Cooler/ Kitchen Equipment / Kitchen Crockery
20,000400To look after an aged person per year
25,000500Dining Hall Furniture
50,0001000Dormitory Construction/Laundry Equipment / Freezer Box
1 Lakh2000Single Room in memory of your beloved ones./fixed deposit towards corpus fund.
1.5 Lakhs3000Double Room
2 Lakhs4000Medical Equipment / Physiotherapy Equipment
2.5 Lakhs5000Ambulance
3 Lakhs6000Sharing Room Unit
5 Lakhs10,000Construction Dormitory (20 Beds)

Donation for Cow Shelter

We are planning to construct “Shri KAMDHENU GAU SEVA KENDRA” with adequate facilities for Medical Treatment and housing for 100 cows.

Requirement for “Shri kamdhenu Gau Seva Kendra”
AmountDetails
Rs.2,51,000Compound wall with Gate
Rs.3,51,000Cow Shed Construction
Rs.50,000Ceiling Fans for Shed 50 nos. at Rs. 1000 each
Rs.1,51,000Water supply facilities with Tube-Well
Rs.2,50,000Grass Godown
Special Scheme for “Shri Kamdhenu Gau Seva Kendra”
AmountDetails
Rs.5000Operation and Medical expense for 1 cow
Rs.3501One day Fodder expense for 25 cows
Rs.11,001Kansar Seva for cows On Birthday / Gokulashthami/Ekadasi/Paryushan
Rs.2000Ambulance expenses for one cow one time
Life Membership for “Shri Kamdhenu Gau Seva Kendra” (From interest income)
AmountDetails
Rs.1,51,001Seva for 31 cows for 12 months
Rs.75,001Seva for 31 cows for 6 months
Rs.40,001Seva for 31 cows for 3months
Rs.10,000Seva for 31 cows for 1 months
Interests:
         Service to the Cow & mankind, research and developments, Health, Environment, Agriculture, Horticultur, Plantetion etc…….

Vision:
       We will create aditee's own Bio-organic world. 

About me:
          Every day, about 30 consultatio attend and accordingly give the respective Ayurvedic Diagnosis and Panchagavya (cow's medicinal products) Treatments. Here each and everyone may step in and receive the healing blessing of Go Mata, The Mother of Mankind, Goddess of Gods and the Worshiped Deity of Parameshvar, Shri Govinda.

I feel...:          
         (Kamdhenu Gosthhi) is creating a protective layer for resistance of future unexpected exposures. How can we protect ourselves and universe???? Assure profoundly study our safety programs.
Following promise I take to myself:
1- Every day I’ll protect at least a tree.
2- Every week I'll plant a new tree.
3- I’ll do havan (YAGNYA ) and pray to sun for genuine nature & avoid sun ’s warmness.

Our medicines:
Kamdhenu makoya ark
Kamdhenu yogendra rash
Kamdhenu trayodasang google
Kamdhenu rasonadi google
Kamdhenu medohar google
Kamdhenu abhaa google
Kamdhenu kachnar google
Kamdhenu keisor google
Kamdhenu asmarinasak churn
Kamdhenu abipatikar churn
Kamdhenu Ubtan
Kamdhenu soap
Kamdhenu iye drops
Kamdhenu malham
Kamdhenu mazik tail
Kamdhenu chyavanprass
Etc….



  1. Donations: Donations to kamdhenu dham vrindaban are tax exempt in India under Section 80 G of the Income Tax Act.1961.

Friday, March 27, 2015

kidney problem

Displaying 20150304_095413.jpg             this report is only 15 days taken panchagavya medicines after reduce critine 3,7 to 2.2

Sunday, July 27, 2014

Maha panchagavya ghreet

Maha Panchagavya Ghrita – Benefits, Dosage, How To Use, Side Effects, Ingredients, Reference

Maha Panchagavya Ghrita is an Ayurvedic medicine, in herbal ghee form.This medicine has ghee as its base. It is used for preparatory procedure for Panchakarma and also as medicine.
Please note that it is different from Panchagavya ghrita
Maha Panchagavya Ghrita benefits: 
It is used as medicine and also in preparatory procedure called snehakarma for the treatment of fever, epilepsy, fistula, inflammation, piles, liver diseases, anemia, cough and psychiatric conditions.
Synonyms: Maha Panchagavya ghritam, Maha Panchagavy Ghrit
Effect on Tridosha - Calms Vata, Pitta and Kapha.

Maha Panchagavya Ghrita dosage: 
As medicine – quarter to half teaspoon with water, usually before food, once or twice a day, or as directed by Ayurvedic doctor.
For Panchakarma preparation – Snehana procedure, the dose depends on the disease status and the judgement of Ayurvedic doctor.
Maha Panchagavya Ghrita Side Effects: 
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.
In very high dose, it may cause diarrhoea and indigestion.
Maha Panchagavya Ghrita Ingredients: 
96 grams of each of
Dashamoola group of roots -
Bilva – Aegle marmelos
Agnimantha – Premna mucronata
Shyonaka – Oroxylum indicum
Gambhari – Gmelina arborea
Patala – Stereospermum suaveolens
Shalaparni – Desmodium gangeticum
Prinshnaparni – Urarica picta
Gokshura – Tribulus terrestris
Brihati – Solanum indicum
Kantakari – Solanum xanthocarpum,
Triphala – Haritaki (Terminalia chebula), Vibhitaki (Terminalia bellirica) Amla (Emblica officinalis)
Haridra – Turmeric
Daruharidra – Berberis aristata
Kutaja – Holarrhena antidysenterica
Saptaparna – Alstonia scholaris
Apamarga – Achyranthes aspera
Nilini - Indigofera tinctoria
Katurohini – Picrorhiza kurroa
Shampaka – Cassia fistula
Pushkaramoola – Inula racemosa
Phalgumoola – Ficus carica
Duralabha – Alhagi psudalhagi
water for decoction – 12.288 liters, boiled and reduced to 3.072 liters
powders of 12 grams of each of
Bharngi – Clerodendron serratum
Patha – Cissampelos pariera
Adhaki – Cajanus cajan
Kumbha – Operculina turpethum
Nikumbha – Baliospermum montanum
Trikatu – pepper, long pepper and ginger
Rohisha –  Cymbopogon martinii
Murva - Marsdenia tenacissima
Bhutika - Trachyspermum ammi
Bhunimba – Andrographis paniculata
Shreyasi – Piper chaba
Sariva – Hemidesmus indicus
Madayantika – Lawsonia inermis
Agni – Plumbago zeylanica
Nichula - Barringtonia acutangula
Gomaya swarasa – the water extract prepared from cow dung – 768 ml
ksheera – cow milk - 768 ml
Dadhi – cow cheese - 768 ml
Mutra – Cow urine - 768 ml
Ghritham – ghee – 768 grams
The above combination is heated till herbal ghee is prepared.

PANCHAGAVYA

Benefits, Dosage, How To Use, Side Effects, Ingredients, Reference

Panchagavya Ghrita is an Ayurvedic medicine, in herbal ghee form.This medicine has ghee as its base. It is used for preparatory procedure for Panchakarma and also as medicine. Panchagavyam refers to five different components of cow products.
Panchagavya Ghrita benefits: 
It is widely used as medicine and also in preparatory procedure called snehakarma for the treatment of
neurological and psychiatric conditions, fever, liver diseases such as jaundice.
Effect on Tridosha - Calms Pitta and kapha

Panchagavya Ghrita dosage: 
As medicine – quarter to half teaspoon with water, usually before food, once or twice a day, or as directed by Ayurvedic doctor.
For Panchakarma preparation – Snehana procedure, the dose depends on the disease status and the judgement of Ayurvedic doctor.

It is usually administered with warm water.Ghrita Side Effects: 
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.
In very high dose, it may cause diarrhoea and indigestion.

Panchagavya Ghrita Ingredients: 
Gomaya swarasa – the water extract prepared from cow dung – 3.072 liters
ksheera – cow milk – 3.072 liters
Dadhi – cow cheese – 3.072 kg
Mutra – Cow urine – 3.072 liters
Ghritham – ghee – 768 grams
The above combination is heated till herbal ghee is prepared.
Ghrita Side Effects: 
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.
In very high dose, it may cause diarrhoea and indigestion.

Panchagavya Ghrita Ingredients: 
Gomaya swarasa – the water extract prepared from cow dung – 3.072 liters
ksheera – cow milk – 3.072 liters
Dadhi – cow cheese – 3.072 kg
Mutra – Cow urine – 3.072 liters
Ghritham – ghee – 768 grams
The above combination is heated till herbal ghee is prepared.
Ghrita Side Effects: 
There are no known side effects with this medicine. However it is best to use this product under medical supervision. Self medication with this medicine is discouraged.
People with diabetes, high cholesterol, heart diseases and high BP should excise precaution.
In very high dose, it may cause diarrhoea and indigestion.

Panchagavya Ghrita Ingredients: 
Gomaya swarasa – the water extract prepared from cow dung – 3.072 liters
ksheera – cow milk – 3.072 liters
Dadhi – cow cheese – 3.072 kg
Mutra – Cow urine – 3.072 liters
Ghritham – ghee – 768 grams
The above combination is heated till herbal ghee is prepared.

Sunday, November 6, 2011

Effects of Kamdhenu Ark


Effects of Kamdhenu Ark and Active Immunization by Gonadotropin
Releasing Hormone Conjugate (GnRH-BSA) on Gonadosomatic 
Indices (GSI) and Sperm Parameters in Male Mus musculus
Javid Ahmad Ganaie, Varsha Gautam, Vinoy Kumar Shrivastava
*
- Endocrinology Laboratory, Department of Biosciences, Barkatullah University, Bhopal, India
Abstract
Background: Active immunization against GnRH decreases the secretion of gonadotropins and causes cessation of gonadal function, thereby, inducing infertility. Based
on the immunoenhancing activity of Kamdhenu ark (distilled cow urine), this study
was performed to evaluate its effects on the gonadosomatic indices (GSI) and sperm
parameters in male mice receiving a GnRH contraceptive vaccine. 
Methods: Sixty adult male mice of Parke’s strain were divided into three groups of
twenty. Group I served as the controls, while group II was immunized by GnRH-BSA
conjugate (50/0.2/35 µg/ml/g BW) by four intraperitoneal injections at different intervals on days 1, 30, 60 and 90. However, group III was supplemented daily by oral
Kamdhenu ark (100  ppm) along with GnRH-BSA immunizations. The animals were
sacrificed after 30, 60, 90 and 120 days and their testis and epididymis were dissected
out weighed and semen analysis was performed. 
Results: GSI values, sperm motility, sperm count and sperm morphology in male Mus
musculus were decreased significantly in all the experimental groups as compared to
the control group (p<0.01). Kamdhenu ark significantly enhanced the effect of GnRH
vaccine on the aforesaid parameters especially in 90 and 120 days treated groups
(p<0.05).
Conclusion: The changes witnessed in sperm parameters suggested that the GnRHBSA immunization suppressed the activities of gonadotropins and testosterone directly through hypothalamo-hypophysial-gonadal  axis and indirectly by acting on the
testes which may modulate the sperm morphology, sperm count and motility. However, Kamdhenu ark seems to have enhanced these effects because of its immunemodulatory properties too.
Keywords:  GnRH-BSA, Gonadosomatic indices (GSI), Immunization, Kamdhenu ark,  Mus
musculus, Sperm parameters.
To cite this article: Ganaie JA, Gautam V, Shrivastava  VK. Effects of Kamdhenu Ark and Active
Immunization by Gonadotropin Releasing Hormone Conjugate (GnRH-BSA) on Gonadosomatic Indices
(GSI) and Sperm Parameters in Male Mus musculus. J Reprod Infertil. 2011;12(1):3-7.
Background
        onadotropin-releasing hormone (GnRH) con-         
        trols the production of gonadotropins, thereby having an orchestrating effect on the reproductive hormone cascade and spermatogenesis (1).
Active immunization against GnRH has successfully suppressed the secretion of gonadotropins
and decreased sperm production, follicular development, ovulation and conception in male and female mammals (2, 3). Vaccination against GnRH
blocks the hypothalamic-pituitary- gonadal axis. 
Therefore, it can be used as an alternative for
castration and fertility control in farm animals,
companion animals and wildlife species (4-6).
Application of GnRH vaccination in humans has
been suggested for controlling fertility-related
endocrine disorders and gonadal steroid-dependent diseases (7). Active immunization of adult
animals against GnRH causes the loss of synthesis
and secretion of gonadotropins and cessation of
gonadal function as long as the antibody titers
* Corresponding Author: 
Vinoy Kumar Shrivastava,
Endocrinology
Laboratory, Department 
of Bioscience, Barkatullah
University, Bhopal (M.P.)
India.
E-mail: 
vinoyks2001@yahoo.com
Received: May 9, 2010
Accepted: Aug. 10, 2010                                      J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011
JRI Kamdhenu ark and GnRH-BSA immunization
4
remain elevated (8).
It has been reported that cow urine contains all
beneficial elements such as chemical properties,
potentialities and constituents that are capable of
removing all the ill effects and imbalances of
body caused by various infectious agents and
toxicants. In this way, it ensures a protection
against various ailments including the most
dreaded diseases like cancer, diabetes, hepatitis
etc. (9). Kamdhenu ark (distilled cow urine) has
been reported as a strong immunomodulator and
bioenhancer by various researchers (10, 11).
Experimental studies of Rangasamy and Kaliappan revealed the protective effects of cow urine on
haematological, serum biochemical parameters
and immune status of broilers (12). 
The present study attempts to evaluate the
effects of GnRH-BSA immunization on gonadosomatic indices (GSI) and sperm parameters in
male mice and to examine the modulatory role of
Kamdhenu ark following the immunization.
Methods
Sixty adult male mice, Mus musculus, of Parke’s
strain (P), weighing 30±5  g were used in the
study. The animals were divided into three groups
of twenty. The mice in Group I served as the
controls, receiving intraperitoneal Phosphate
Buffered Saline (PBS) injections (100  µl) on the
1
st
, 30
th
, 60
th
 and 90
th
 days, while the mice in
group II were immunized by GnRH-BSA conjugate (50/0.2/35  µg/ml/g BW) (Sigma-Aldrich,
USA) dissolved in 100 µl of phosphate buffered
solution (0.01 N) emulsified with an equal volume
(100  µl) of Freund’s adjuvant (Sigma Aldrich,
USA). GnRH-BSA injections were given intraperitoneally at different intervals, i.e. on days 1
st
 ,
30
th
, 60
th
 and 90
th
 However, the mice in group III .
were supplemented with daily Kamdhenu ark
(100  ppm) (Gaytri Shakti Peeth, India) orally
along with the intraperitoneal injections of GnRHBSA. Five animals from each group were
sacrificed in monthly intervals, i.e. on days 30, 60,
90 and 120 and their testes and epididymides were
quickly dissected. The testes were weighed for
observing gonadosomatic indices [gonad weight/
100  g BW], while the epididymides were processed for semen analysis,  i.e. sperm motility,
sperm count and morphology by Prasad method
(13). Cauda epididymides were dissected out to
release sperms in normal saline (100  mg tissue/ 
2  ml N.S.) for sperm suspension.  For studying
sperm morphology, Leishman`s stain was used
and the slides were finally observed at 400×
magnification (14).
Statistical Analysis: The collected data were analyzed through one way ANOVA and post-hoc
methods using EZANOVA software. P-values
<0.05 or <0.01 were considered significant while
values <0.001 were considered as highly significant.
Results
GSI values decreased in all the experimental
groups compared to the control group. However,
more significant decrease in GSI was observed in
the group treated by Kamdhenu ark along with
GnRH-BSA, especially in the later part of the
experiment (p<0.01) (Table 1). Moreover, sperm
motility and sperm count significantly decreased
throughout the investigation in all the treated
groups compared to the control group (p<0.01)
(Table 2). However, some mice immunized by
GnRH-BSA + Kamdhenu ark also showed decreased values for sperm motility and count than
the GnRH-BSA immunized groups (p<0.05). The
Table 1. Gonadosomatic indices (GSI) in the experimental and control groups of
male mice, Mus musculus,after different intervals
Group
GSI (gonad weight/100 g BW)
Duration
30 days 60 days 90 days 120 days
Control  0.40 ± 0.02  0.43 ± 0.05  0.50 ± 0.01  0.54 ± 0.04
GnRH-BSA   0.36 ± 0.06 0.30  ± 0.02
a
* 0.23 ± 0.00
a
 0.16 ± 0.00
a
GnRH-BSA + KA    0.32±0.03  0.26± 0.01
a
0.19±0.01
ab
0.12±0.00
ab
Mean ± SEM of five animals (Accuracy of calculation up to two decimal digits)
a
 = Significant difference with the controls in the same column (p< 0.01) 
b
= Significant difference with GnRH-BSA groups in the same column (p< 0.01)
* = Significant differences (p< 0.05)                                                                              J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011
                                                                                            Ganaie JA, et al.  JRI
5
percentage of morphologically normal sperm decreased significantly with increased percentage of
abnormal forms of sperms, i.e. pin head, large
head, oval head, double head, head less, bent
neck, looping mid piece, coiled-tail, double-tailed,
tailless in all the experimental groups as compared
to the control group (p<0.01) (Table 3, Figure 1).
Moreover, some significant alterations in normal
sperm morphology, such as large head, headless
and pin head sperm were also observed in GnRHBSA + Kamdhenu ark treated group when compared with GnRH-BSA, especially in the later part
of the experiment (p<0.01).
Discussion
The endocrine effects of active immunization
against GnRH have been studied in a variety of
young adult male and female animals (15-17).
Experimental studies have demonstrated decreases in gonadotropins, sperm production,
follicular development, ovulation and conception
after immunization against GnRH, chemically
conjugated to a carrier protein. GnRH immuneization affected sperm motility and sperm counts
in ram lambs, boars and colts (18, 19). Several
other experimental studies have revealed the
deleterious effects of immunization against GnRH
on different sperm parameters in rats, bulls,
stallions, cats and dogs (20-24).
Cow urine has been tested for its immunomodulatory properties that enhance both cellular
and humoral immune responses (25, 26). Kamdhenu ark (distilled cow urine) has been reported to
increase the humoral immunity in rats (27). 
Chauhan  et al., (2004) observed that Kamdhenu
ark may modulate the immune responses because
it increases the secretion of interleukin-1 and 2
Table 2. Sperm motility and sperm count in the experimental and control groups of male mice, Mus musculus, after
different intervals
Parameters Group
Duration
30 days 60 days 90 days 120 days
Sperm Motility (%)
Control  59.00±4.33  63.76±2.77  65.05±2.31  69.60±3.19
GnRH-BSA   39.40±3.81
a
 21.56±1.36
 a
 13.00±2.11
 a
 9.40±1.14
 a
GnRH-BSA+ KA  33.80±1.72
 a
17.06±1.00
 ab
* 10.46±1.65
 a
7.16±0.95
 a
Sperm Count (million/ml)
Control  62.00±3.18 68.60±2.10  75.50±3.76 78.00±2.11
GnRH-BSA   49.10±2.65
 a
35.22±3.21
a
21.00±2.20
a
16.42±1.78
a
GnRH-BSA + KA  44.18±2.82
a
 26.12±2.00
 ab
* 18.30±1.90
a
 12.34±1.10
ab
*
Mean ± SEM of five animals (Accuracy of calculation up to two decimal digits)
a
 = Significant difference with the controls in the same column (p< 0.01) 
b
= Significant difference with the GnRH-BSA groups in the same column (p< 0.01)
* = Significant differences (p< 0.05)
Figure 1. Normal morphological sperm forms in the controls
(A) and morphologically abnormal sperms after GnRH-BSA
and Kamdhenu ark along with GnRH-BSA administration (BI) in male Mus musculus.                                      J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011
JRI Kamdhenu ark and GnRH-BSA immunization
6
(28). Recently, Ganaie and Shrivastava reported
the modulatory effects of Kamdhenu ark on
GnRH-BSA immunization in female mice (29). 
In corroboration to above studies, our study also
revealed that GnRH-BSA immunization significantly decreased the values of GSI, sperm motility, count and morphology in male Mus musculus.
The aforesaid parameters diminished more significantly in the group supplemented with Kamdhenu
ark along with GnRH-BSA immunization. All
these changes in GSI and sperm parameters
suggested that GnRH-BSA immunization could
have directly suppressed the activities of gonadotropins and testosterone through hypothalamohypophysial-gonadal axis or might have indirectly
affected the testicular tissue. However, more
significant decreases in the parameters after
Kamdhenu ark supplementation may be because
of its modulatory and bioenhancing properties.
Acknowledgement
The authors gratefully acknowledge the help and
financial support of Professor Meenakshi Benerjee, the head of Department of Biosciences,
Barkatullah University, Bhopal (M.P), India.
References
1. Garner LL, Campbell GT, Blake CA. Luteinizing
hormone (LH)-releasing hormone: chronic effects
on LH and follicle-stimulating hormone cells and
secretion in adult male rats. Endocrinology. 1990;
126(2):992-100.
2. Hoskinson RM, Rigby RD, Mattner PE, Huynh VL,
D'Occhio M, Neish A, et al. Vaxstrate: an anti reproductive vaccine for cattle. Aust J Biotechnol.
1990;4(3):166-70, 176.
3. Prendiville DJ, Enright WJ, Crowe MA, Vaughan L,
Roche JF. Immunization of prepubertal beef heifers
against gonadotropin-releasing hormone: immune,
estrus, ovarian, and growth responses. J Anim Sci.
1995;73(10):3030-7.
4. Bonneau M, Enright WJ. Immunocastration in cattle
and pigs. Livest Prod Sci. 1995;42(2-3):193-200.
5. Robbins SC, Jelinski MD, Stotish RL. Assessment
of the immunological and biological efficacy of two
different doses of a recombinant GnRH vaccine in
domestic male and female cats (Felis catus). J
Reprod Immunol. 2004;64(1-2):107-19.
6. Miller LA, Johns BE, Killian GJ. Immunocontraception of white-tailed deer with GnRH vaccine. Am J
Reprod Immunol. 2000;44(5):266-74.
Table 3. Percentage of normal and abnormal sperm morphology in the experimental and control groups of male mice, Mus musculus, after different intervals
Days Groups
Normal
 (%)
Abnormal (%)
Pin head
Large
head
Oval
head
Double
head
Head less Bent neck
Looping
mid piece
Coiled tail
Double
tailed
Tail-less
30 
Control  58.44±2.12 5.0±0.35 1.0±0.35 4.0±0.79 1.2±0.65 4.0±1.17 3.0±0.86 4.4±1.60 1.6±0.30 0.0±0.0 2.5±1.00
GnRHBSA
27.77±0.78
 a
8.4±1.03  5.0±0.79  5.80±1.29  2.2±0.74  5.8±1.08  6.4±1.03  6.2±0.65  2.4±0.75  2.2±0.96  5.4±1.15
GnRHBSA+ KA
24.00±1.22
 ab*
 7.6±0.57 4.20±0.65 6.4±1.03 2.4±0.75 8.6±0.90 5.6±1.3 6.5±2.19 1.80±0.24 1.66±0.51 2.5±0.75
60 
Control  64.00±1.41 5.4±0.57 4.2±0.65 3.4±0.57 0.60±0.00 5.0±1.36 3.4±0.57 4.2±0.65 2.5±0.55 1.33±0.51 0.80±0.14
GnRHBSA
23.20±1.16 a  11.2±0.65  10.20±1.74  7.20±0.50  2.60±0.90  7.80±0.65  9.4±1.15  10.80±1.38  4.0±0.70  2.00±0.00  3.5±0.87
GnRHBSA+ KA
20.65±0.94 a 10.80±0.45 6.4±0.59 7.4±0.90 0.00±0.00 11.80±1.43 10.00±1.76 9.60±0.51 2.50±0.48 3.0±1.11 5.80±2.38
90 
Control  67.10±1.74 4.5±0.65 2.60±1.03 2.2±0.41 0.00±0.00 3.401.71 2.60±0.90 1.60±0.83 0.00±0.00 2.60±1.03 1.0±0.21
GnRHBSA
14.24±0.48 a  13.60±1.15  5.80±0.93  6.0±1.00  1.20±0.65  10.40±0.75  12.0±0.79  17.80±1.94  2.50±1.15  1.0±0.25  8.0±0.65
GnRHBSA+ KA
12.72±0.23 ab 13.20±1.19 8.80±0.96 5.80±1.55 2.2±0.96 13.40±1.03 9.5±2.07 10.80±1.29 3.0±0.79 2.5±0.83 11.0±1.76
120 
Control  72.00±1.66 2.60±0.41 2.20±0.39 1.0±0.50 0.00±0.00 2.80±1.29 1.20±0.54 2.0±0.44 1.00±0.00 0.00±0.00 2.5±1.15
GnRHBSA
10.33±0.25
 a
12.80±1.55  7.00±0.79  6.00±0.79  2.80±0.96  16.00±1.36  17.20±0.96  20.60±1.95  5.00±1.11  2.80±0.41  9.50±1.68
GnRHBSA+ KA
7.95±0.40
 ab
 14.60±1.03 11.00±0.79 7.20±0.82 3.80±0.96 17.60±1.07 15.00±1.83 14.25±2.21 4.60±1.15 4.0±1.17 12.50±0.65
Mean ± SEM of five animals (Accuracy of calculation up to two decimal digits)
a = Significant difference with the controls in the same column (p< 0.01) 
b = Significant difference with GnRH-BSA groups in the same column (p< 0.01)
* = Significant differences (p< 0.05)                                                                               J Reprod Infertil, Vol 12, No 1, Jan/ Mar 2011
                                                                                            Ganaie JA, et al.  JRI
7
7. Simms MS, Scholfield DP, Jacobs E, Michaeli D,
Broome P, Humphreys JE, et al. Anti-GnRH antibodies can induce castrate levels of testosterone in
patients with advanced prostate cancer. Br J Cancer.
2000;83(4):443-6.
8. Kumar N, Savage T, DeJesus W, Tsong YY, Didolkar A, Sundaram K. Chronic toxicity and reversibility of antifertility effect of immunization against
gonadotropin-releasing hormone in male rats and
rabbits. Toxicol Sci. 2000;53(1):92-9.
9. Bhadauria  H.  Gomutra-Ek  Chamatkari  Aushadhi
(Cow urine- A Magical therapy). Vish Ayur Patrika.
2002;5:71-4.
10. Chauhan RS, Singh BP, Singhal LK. Immunomodulation with kamdhenu ark in mice. J Immunol
Immunopathol. 2001;3(1):74-7.
11. Garg N, Chauhan RS, Kumar A. Assessing the
effect of cow urine on immunity of white leghorn
layers. International Society for Animal Hugges
(ISAH). 2005;2:81-3.
12. Mathivanan R, Kalaiarasi K. Panchagavya and
Andrographis paniculata as alternatives to antibiotic growth promoters on haematological, serum
biochemical parameters and immune status of
broilers. J Poult Sci. 2007;44(2):198-204.
13. Prasad MR, Chinoy NJ, Kadam KM. Changes in
succinic dehydrogenase levels in the rat epididymis
under normal and altered  physiologic conditions.
Fertil Steril. 1972;23(3):186-90.
14. Highland HN, Rao MV, Chinoy NJ, Shah VC. Analysis of the functional and nuclear integrity of
human spermatozoa. Int J Fertil. 1991;36(1):43-7.
15. Esbenshade KL, Britt JH. Active immunization of
gilts against gonadotropin-releasing hormone: effects on secretion of gonadotropins, reproductive
function, and responses to agonists of gonadotropin-releasing hormone. Biol Reprod. 1985;33
(3):569-77.
16. Johnson HE, DeAvila DM, Chang CF, Reeves JJ.
Active immunization of heifers against luteinizing
hormone-releasing hormone, human chorionic
gonadotropin and bovine luteinizing hormone. J
Anim Sci. 1988;66(3):719-26.
17. Meloen RH, Turkstra JA, Lankhof H, Puijk WC,
Schaaper WM, Dijkstra G, et al. Efficient immunecastration of male piglets by immunoneutralization
of GnRH using a new GnRH-like peptide. Vaccine.
1994;12(8):741-6.
18. Grizzle TB, Esbenshade KL, Johnson BH. Active
immunization of boars against gonadotrop in releasing hormone. I. Effects on reproductive parameters. Theriogenology. 1987;27(4):571-80.
19. Dowsett KF, Pattie WA, Knott LM, Jackson AE,
Hoskinson RM, Rigby RP, et al. A preliminary
study of immunological castration in colts. J
Reprod Fertil Suppl. 1991;44:183-90.
20. McLachlan RI, Wreford NG, Tsonis C, De Kretser
DM, Robertson DM. Testosterone effects on
spermatogenesis in the gonadotropin-releasing hormone-immunized rat. Biol Reprod. 1994;50(2):
271-80.
21. Cook RB, Popp JD, Kastelic JP, Robbins S, Harland R. The effects of active immunization against
gnRH on testicular development, feedlot performance, and carcass characteristics of beef bulls. J
Anim Sci. 2000;78(11):2778-83.
22. Janett F, Stump R, Burger D, Thun R. Suppression
of testicular function and sexual behavior by vaccination against GnRH (Equity) in the adult stallion. Anim Reprod Sci. 2009;115(1-4):88-102.
23. Levy JK, Miller LA, Cynda Crawford P, Ritchey
JW, Ross MK, Fagerstone KA. GnRH immunecontraception of male cats. Theriogenology. 2004;
62(6):1116-30.
24. Ross MK, Miller LA, Crawford PC, Ritchey JW,
Fagerstone KA. GnRH  immunocontraception in
cats. In: Baker H, Boyle S, Griffin B, editors. Proceedings of the 2004 ACCD International Symposium on Non-surgical Methods for Pet Population
Control; 2004 June 24-27; Denver, Colorado, Belle
Court (Portland): ACCD Press; 2005. p.113-5. 
25. Prabhakar K, Singh GK, Chauhan RS, Singh DD.
Effect of cow urine on lymphocyte proliferation in
developing stages of chicks. Indian Cow. 2004;1
(2):3-5.
26. Kumar R, Chauhan RS, Singhal LK, Singh AK,
Singh DD. A comparative study on immunostimulatory effects of Kamdhenu Ark and Vasant Kusumakar in mice. J Immunol Immunopathol. 2002;4
(1-2):104-6.
27. Garg N, Chauhan RS. Kamdhenu ark changes
humoral immunity in rat. In: National Symposium
on Molecular Biology in India- A Post Graduate
Update; 2003 Jan 18, Gwalior, India, Gwalior
(Madhya Pradesh): Cancer Hospital and Research
Institute; 2003. p. 98.
28. Chauhan RS, Singh DD, Singhal LK, Kumar R.
Effect of cow urine on interleukin-1 and 2. J
Immunol Immunopathol. 2004;6(1):38-9.
29. Ganaie JA, Shrivastava VK. Effects of gonadotropin releasing hormone conjugate immunization
and bioenhancing role of Kamdhenu ark on estrous
cycle serum estradiol and progesterone levels in
female Mus musculus. Iran J Reprod Med. 2010;8
(2):70-5.                     

Monday, May 9, 2011

About Cancer Treatment

About Cancer Treatment

Jorge Valdés Romo , Said about her wife
Gopa's Pita Ji wrote:

Dear Doctor:

Patiente Name: María Skarica Zúñiga.
On 18th August I sent info regarding the improving conditions of Maria after following the treatment after surgery. End October has been taken Thoracic X-ray, Ultrasound and Mammography.
Yesterday we showed the reports to the Doctor and he found them so good that he indicated a new control after 6 months. And he reduced the calcium dosage to one time every three months injection.

You may imagine how happy we are. She feel healthy and without any side-effect of medicines or symptoms of cancer, osteoporosis or any other sickness.

Our consultation now is medicines and in which dosage should she continue taking according the new reports. We expect anxiously your reply.

Greeting you attentively,
Jorge Valdes Romo.
Santiago - Chile, South America.


Estimado doctor:

Con fecha 18 de agosto recién pasado le informé el estado de María luego de haber seguido sus indicaciones para el tratamiento postoperatorio. A fines de octubre se tomó radiografía de torax, ecotomografía y mamografía, de los que le adjunto copia de sus informes. Ayer le llevamos al médico alópata que le controla estos mismo informes y los encontró tan buenos que le indicó nuevo control en seis meses más y le redujo la dosis de calcio a una vez cada tres meses.

Podrá imaginarse lo contento que estamos. Ella se siente sana y sin ninguna secuela de la enfermedad. Nuestra consulta es qué remedios y en qué cantidad debe continuar tomando de acuerdo al resultado de los informes. Con ansia esperamos su respuesta. Lo saluda muy atentamente.

--
Jorge Valdés Romo

Desde Santiago de Chile - La paciente es María Skarica Zúñiga

Monday, February 14, 2011

Monday, December 27, 2010

To stay in resort 1 US $ per day (24 Hours)

Dear Friends,

We have built nice resort in a true natural ways , The place is in Balangir district of Orissa of India . It is quite far away from crowded population and pollution of carbon and noise  , The resort is in Mountain Provided with all basic necessity , We will arrange utensils and everything if the Guests wanted to prepare food them-self otherwise we will provide the food twice in a day at the cost of  only 1 $ each time , So guest have to pay just 3 $ in a day including food and accommodation , No hidden cost , No tax , no extra charges . Internet Facilities is also provided at an Additional cost . So guest no need to rush to somewhere else to look for the internet . We are encouraging Urban peoples to experience the beauty of village life at a quite affordable price .

We support green technology hence we are in the process to install wind-turbine to generate the electricity instead of depending upon traditional electricity .

This place would be quite suitable for those enthusiastic/writers/thinkers and who wants to get away from city crowded life and really wants to need peace full time with out any disturbance with all basic necessity at affordable price  . Nearby the resort there is small Ayurveda free  treatment center is also there , Cancer , diabetic and other chronic diseases can be cured at a quite affordable prices .

We have built a nice resort in a true natural way it is located in Bolangir district of Orissa of India , the place is quite far away from crowded population , Per day we charge just 1 $ and 2 $ for food , Internet facility would be available on additional cost . Please come and stay for months together at affordable price .

If you have any query/request to book the place please email to info@sevika.org .The contact no is +918018911018 +919439422804

400 Words Contents .

We have built a nice resort in a true natural way it is located in Bolangir district of Orissa of India , the place is quite far away from crowded population , Per day we charge just 1 $ and 2 $ for food , Internet facility would be available on additional cost . Please come and stay for months together at affordable price .

If you have any query/request to book the place please email to info@sevika.org .The contact no is +918018911018 + 919439422804

Wednesday, December 1, 2010

HIV & AIDS TREATMENT !

PLZ CONTACT:
KAMDHENU PANCHAGAVYA RESEARCH CENTRE(HOSPITAL),PATNAGARH,ORISSA,INDIA.
MOB.NO- +91 8018911018,9439422804.

HIV & AIDS

What is AIDS?

AIDS stands for: Acquired Immune Deficiency Syndrome
AIDS is a medical condition. A person is diagnosed with AIDS when their immune system is too weak to fight off infections.
Since AIDS was first identified in the early 1980s, an unprecedented number of people have been affected by the global AIDS epidemic. Today, there are an estimated 33.3 million people living with HIV and AIDS worldwide.

What causes AIDS?

AIDS is caused by HIV.
HIV is a virus that gradually attacks immune system cells. As HIV progressively damages these cells, the body becomes more vulnerable to infections, which it will have difficulty in fighting off.  It is at the point of very advanced HIV infection that a person is said to have AIDS. It can be years before HIV has damaged the immune system enough for AIDS to develop.

What are the symptoms of AIDS?

A person is diagnosed with AIDS when they have developed an AIDS related condition or symptom, called an opportunistic infection, or an AIDS related cancer. The infections are called ‘opportunistic’ because they take advantage of the opportunity offered by a weakened immune system.
It is possible for someone to be diagnosed with AIDS even if they have not developed an opportunistic infection. AIDS can be diagnosed when the number of immune system cells (CD4 cells) in the blood of an HIV positive person drops below a certain level.

Is there a cure for AIDS?

Worryingly, many people think there is a 'cure' for AIDS - which makes them feel safer, and perhaps take risks that they otherwise wouldn’t. However, there is still no cure for AIDS. The only way to stay safe is to be aware of how HIV is transmitted and how to prevent HIV infection.

How many people have died from AIDS?

Since the first cases of AIDS were identified in 1981, more than 25 million people have died from AIDS. An estimated 1.8 million people died as a result of AIDS in 2009 alone.
Although there is no cure for AIDS, HIV infection can be prevented, and those living with HIV can take antiretroviral drugs to delay the onset of AIDS. However, in many countries across the world access to prevention and treatment services is limited. Global leaders have pledged to work towards universal access to HIV prevention and care, so that millions of deaths can be averted.

How is AIDS treated?

Antiretroviral treatment can prolong the time between HIV infection and the onset of AIDS. Modern combination therapy is highly effective and someone with HIV who is taking treatment could live for the rest of their life without developing AIDS.
An AIDS diagnosis does not necessarily equate to a death sentence. Many people can still benefit from starting antiretroviral therapy even once they have developed an AIDS defining illness. Better treatment and prevention for opportunistic infections have also helped to improve the quality and length of life for those diagnosed with AIDS.
Treating some opportunistic infections is easier than others. Infections such as herpes zoster and candidiasis of the mouth, throat or vagina, can be managed effectively in most environments. On the other hand, more complex infections such as toxoplasmosis, need advanced medical equipment and infrastructure, which are lacking in many resource-poor areas.
It is also important that treatment is provided for AIDS related pain, which is experienced by almost all people in the very advanced stages of HIV infection.

Why do people still develop AIDS today?

Even though antiretroviral treatment can prevent the onset of AIDS in a person living with HIV, many people are still diagnosed with AIDS today. There are four main reasons for this:
  • In many resource-poor countries antiretroviral treatment is not widely available. Even in wealthier countries, such as America, many individuals are not covered by health insurance and cannot afford treatment. 
  • Some people who became infected with HIV in the early years of the epidemic before combination therapy was available, have subsequently developed drug resistance and therefore have limited treatment options.
  • Many people are never tested for HIV and only become aware they are infected with the virus once they have developed an AIDS related illness. These people are at a higher risk of mortality, as they tend to respond less well to treatment at this stage.
  • Sometimes people taking treatment are unable to adhere to, or tolerate the side effects of drugs.

Caring for a person with AIDS

In the later stages of AIDS, a person will need palliative care and emotional support. In many parts of the world, friends, family and AIDS organisations provide home based care. This is particularly the case in countries with high HIV prevalence and overstretched healthcare systems.
End of life care becomes necessary when a person has reached the very final stages of AIDS. At this stage, preparing for death and open discussion about whether a person is going to die often helps in addressing concerns and ensuring final wishes are followed.

The global AIDS epidemic

Around 2.6 million people became infected with HIV in 2009. Sub-Saharan Africa has been hardest hit by the epidemic; in 2009 over two-thirds of AIDS deaths were in this region.
Asia, HIV and AIDS causes a greater loss of productivity than any other disease. An adult’s most productive years are also their most reproductive and so many of the age group who have died from AIDS have left children behind. In sub-Saharan Africa the AIDS epidemic has orphaned nearly 15 million children.
In recent years, the response to the epidemic has been intensified; in the past ten years in low- and middle-income countries there has been a 6-fold increase in spending for HIV and AIDS. The number of people on antiretroviral treatment has increased, the annual number of AIDS deaths has declined, and the global percentage of people infected with HIV has stabilised.
However, recent achievements should not lead to complacent attitudes. In all parts of the world, people living with HIV still face AIDS related stigma and discrimination, and many people still cannot access sufficient HIV treatment and care. In America and some countries of Western and Central and Eastern Europe, infection rates are rising, indicating that HIV prevention is just as important now as it ever has been. Prevention efforts that have proved to be effective need to be scaled-up and treatment targets reached. Commitments from national governments right down to the community level need to be intensified and subsequently met, so that one day the world might see an end to the global AIDS epidemic.

Learn more about HIV and AIDS

In addition to the hundreds of informative pages about HIV and AIDS, the AVERT website has interactive ways to learn more about HIV and AIDS.
  • The AVERT AIDS Game is a great way to see how much you know about HIV and AIDS.
  • You can test your knowledge of HIV and AIDS by trying one of our online quizzes.
  • Our photo gallery has hundreds of HIV and AIDS related photos from around the world.
  • The AVERT video gallery has a number of short videos related to HIV and AIDS.
  • Finally, you can read stories that have been sent to us from people who are either living with HIV or who have been affected by HIV and AIDS.